glp-1 weight loss marketing FuturHealth: GLP-1s + Meals = Better Results 02/27/2025 Is GLP-1 Marketing Attacking Our

Additionally, real-world pharmacovigilance data highlight sensory adverse events (particularly dysgeusia) that appear more frequently in clinical practice than in controlled trials, suggesting under recognition of taste-related disturbances in research settings (159)

Zhang, L., Yu, W.-J., Zhu, H., Li, H.-F

This is where dietitians play a vital role

An important nuance: while the trials did not publish detailed BMI-stratified results in their primary papers, the data consistently shows that higher baseline BMI correlates with greater absolute weight loss in kilograms, while lower baseline BMI correlates with greater percentage weight loss

In our study, pretreatment HbA1C level was the dominant factor that affected GLP-1 M treatment outcome in the current analysis

Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical Trial